FOI Request
- Disclosure ID
- FOI/03327
- Request Date
- October 17, 2019
- Subject
- Colorectal Cancer (CRC)
- Description
Are you able to answer the question as within your health trust how many patients have been treated in the past 6 months with the following agent – regardless of diagnosis;
Aflibercept
Bevacizumab
Capecitabine
CAPIRI
CAPOX
Cetuximab
Docetaxel
Irinotecan
FOLFIRI
FOLFOX
Oxaliplatin
Panitumumab
Pembrolizumab
Nivolumab
Raltitrexed
Ramucirumab
Regorafenib
Sorafenib
5FU only
Tegafur Uracil + 5FU
Trifluridine–tipiracil
XELOX
- Response
Please see the figures below where the pharmacy has issued the listed products to a ward or a patient in the last 6 months:
AFLIBERCEPT – 2355
CAPECITABINE – 35897
CETUXIMAB – 262
DOCETAXEL – 455
IRINOTECAN – 300
NIVOLUMAB – 102
OXALIPLATINÂ – 1138
PANITUMUMAB – 80
PEMBROLIZUMAB – 435
RALTITREXED – 1
REGORAFENIB – 231
SORAFENIB – 448